| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/11/2004 | US20040047842 Monascus purpureus mutants and their use in preparing fermentation products having blood pressure lowering activity |
| 03/11/2004 | US20040047835 Combinations of drug conjugates with other therapeutic agents, including chemotherapy drugs. The invention also provides methods of using the combinations for the treatment of diseases associated with cell proliferation such as tumors |
| 03/11/2004 | US20040047834 An agent for promoting excretion of an accumulative chlorine compound comprising a pharmaceutically acceptable anion exchange resin, which is a novel agent that is for promoting the excretion of an accumulative chlorine compound and is |
| 03/11/2004 | US20040047824 Topical use containing at least one oxidation-sensitive hydrophilic active principle and at least one maleic anhydride copolymer, comprising one or more maleic anhydride comonomers and one or more comonomers selected from the group |
| 03/11/2004 | US20040047811 Aerodynamically light particles for pulmonary drug delivery |
| 03/11/2004 | US20040047810 Microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the |
| 03/11/2004 | US20040047809 An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter of |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/11/2004 | US20040047763 Anti-microbial systems and methods |
| 03/11/2004 | US20040045805 Novel process for preparing and harvesting crystalline particles |
| 03/11/2004 | DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity |
| 03/11/2004 | DE10241889A1 Cosmetic or dermatological compositions, e.g. useful for preventing or treating inflammatory skin conditions, sensitive or dry skin, include a quinolinic acid compound |
| 03/11/2004 | DE10241073A1 Kosmetikum mit aktivierbaren Pflegekomponenten Cosmetic with activatable care components |
| 03/11/2004 | DE10240989A1 Zusammensetzung und deren Verwendung als pharmazeutische oder kosmetische Formulierung zur äußerlichen Anwendung Composition and its use as a pharmaceutical or cosmetic formulation for external use |
| 03/11/2004 | DE10240418A1 Formulierung zur Einschleusung von Nukleinsäuren in eukaryotische Zellen Formulation for the introduction of nucleic acids in eukaryotic cells |
| 03/11/2004 | DE10240417A1 Decoy-Oligonukleotid-Hemmung der CD40-Expression Decoy Oligonucleotide inhibition of CD40 expression |
| 03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
| 03/11/2004 | DE10239161A1 Stimulating gastric function without causing undesirable side-effects, using nutritional supplement containing vitamin C and magnesium |
| 03/11/2004 | DE10238722A1 Improving attention, concentration, cognition, learning and/or memory performance, using selective phosphodiesterase 9A inhibitors, preferably 4H-pyrazolo-(3,4-d)-pyrimidin-4-one derivatives |
| 03/11/2004 | DE10237442A1 Hochverzweigte, niedrig substituierte Stärkeprodukte Highly branched, low-substituted starch products |
| 03/11/2004 | CA2706622A1 Lps activation of phagocytic activity |
| 03/11/2004 | CA2513021A1 Process to prepare psorospermin |
| 03/11/2004 | CA2502734A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | CA2501424A1 Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
| 03/11/2004 | CA2497597A1 Methods for identifying subjects at risk of melanoma and treatments |
| 03/11/2004 | CA2497240A1 Methods of promoting osteogenesis |
| 03/11/2004 | CA2497161A1 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/11/2004 | CA2497136A1 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 03/11/2004 | CA2497121A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
| 03/11/2004 | CA2497116A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 03/11/2004 | CA2497114A1 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 03/11/2004 | CA2497112A1 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 03/11/2004 | CA2497086A1 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | CA2497048A1 Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496904A1 Genetic suppression and replacement |
| 03/11/2004 | CA2496887A1 Oxytocin inhibitors |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496867A1 Therapeutic treatment methods |
| 03/11/2004 | CA2496806A1 Oral liquid tolterodine composition |
| 03/11/2004 | CA2496798A1 Embossable and writable multilaminate backing construction |
| 03/11/2004 | CA2496796A1 Medicinal product packaging |
| 03/11/2004 | CA2496795A1 Compositions and methods for treating cardiovascular disease |
| 03/11/2004 | CA2496769A1 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 03/11/2004 | CA2496695A1 New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno{2,3-d}pyrimidine |
| 03/11/2004 | CA2496612A1 Embolization |
| 03/11/2004 | CA2496577A1 Combination therapy for treatment of fibrotic disorders |
| 03/11/2004 | CA2496550A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/11/2004 | CA2496547A1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 03/11/2004 | CA2496459A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 03/11/2004 | CA2496453A1 Preventing or treating epithelial tissue damage or hair loss |
| 03/11/2004 | CA2496452A1 Inhibitors of post-amadori advanced glycation end products |
| 03/11/2004 | CA2496314A1 Methods of treating idiopathic pulmonary fibrosis |
| 03/11/2004 | CA2495915A1 Indoles having anti-diabetic activity |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | CA2495882A1 Agents and methods for enhancing bone formation |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |
| 03/11/2004 | CA2495340A1 Method and device for producing formic acid formates and use of said formates |
| 03/11/2004 | CA2495330A1 Estrogen replacement regimen |
| 03/11/2004 | CA2495192A1 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| 03/11/2004 | CA2495144A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 03/11/2004 | CA2495069A1 Breath freshening and oral cleansing product using citral |
| 03/11/2004 | CA2495064A1 Breath freshening and oral cleansing product using salicylaldehyde |
| 03/11/2004 | CA2495057A1 Breath freshening and oral cleansing product |
| 03/11/2004 | CA2493199A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | CA2492645A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 03/11/2004 | CA2488739A1 Nitrogen-containing aromatic derivatives |
| 03/10/2004 | EP1396547A1 Arachidonic acid metabolites and modulation of mitosis and apoptosis of cells |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396494A1 Magnesium (-)hydroxycitrate and its applications |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |
| 03/10/2004 | EP1396491A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors |
| 03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof |
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
| 03/10/2004 | EP1396273A1 Bicyclo(2.2.1.)heptanes and related compounds |
| 03/10/2004 | EP1396270A1 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis |
| 03/10/2004 | EP1396269A1 Boronic acid salts of multivalent metals used in the preparation of a medicament for treating thrombosis |
| 03/10/2004 | EP1396268A1 Stable oxazaphosphorine-2-mercaptoethanesulphonate formulations |
| 03/10/2004 | EP1396267A2 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 03/10/2004 | EP1396266A1 Aqueous cilostazol preparation for injection |
| 03/10/2004 | EP1396265A1 Ion exchange resins for alleviation of upper gastrointestinal irritation |
| 03/10/2004 | EP1396264A1 Agents for relieving eye controlling function error |
| 03/10/2004 | EP1396262A1 Cosmetic product containing activable care components |
| 03/10/2004 | EP1396261A1 Skincare composition containing caffeine |
| 03/10/2004 | EP1395686A2 Method and nucleic acids for the differentiation of prostate tumors |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/10/2004 | EP1395599A1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives |
| 03/10/2004 | EP1395596A2 Methods for preparation and use of psorospermin analogs |
| 03/10/2004 | EP1395595A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative |
| 03/10/2004 | EP1395594A1 New benzylaminopyrimidines |
| 03/10/2004 | EP1395593A1 Novel pyrazolopyrimidinethione derivatives. preparation methods thereof and their use as therapeutics for erectile dysfunction |
| 03/10/2004 | EP1395592A1 Novel pyridylmethylaminopyrimidines |
| 03/10/2004 | EP1395591A1 Corticotropin releasing factor antagonists |
| 03/10/2004 | EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists |
| 03/10/2004 | EP1395589A1 Imidazo-triazine derivatives as pde 5 inhibitors |
| 03/10/2004 | EP1395587A1 Process for the preparation of imipenem |
| 03/10/2004 | EP1395586A2 Method for the production of zolpidem |